Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.


Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer therapies cause acute and late toxicities that may be underreported, underrecognized, and undertreated. Recent advances in cancer treatment have led to changes in the incidence, nature, and severity of oral complications. As the number of survivors increases, it is becoming increasingly recognized that the aggressive management of oral toxicities is needed to ensure optimal long-term oral health and general well-being. Advances in care have had an impact on previously recognized oral complications and are leading to newly recognized adverse effects. Here, the authors briefly review advances in cancer therapy, including recent advances in surgery, oral care, radiation therapy, hematopoietic cell transplantation, and medical oncology; describe how these advances affect oral health; and discuss the frequent and/or severe oral health complications associated with cancer and cancer treatment and their effect upon long-term health. Although some of the acute oral toxicities of cancer therapies may be reduced, they remain essentially unavoidable. The significant impact of long-term complications requires increased awareness and recognition to promote prevention and appropriate intervention. It is therefore important for the primary oncologist to be aware of these complications so that appropriate measures can be implemented in a timely manner. Prevention and management is best provided via multidisciplinary health care teams, which must be integrated and communicate effectively in order to provide the best patient care in a coordinated manner at the appropriate time.

DOI: 10.3322/caac.21157
Citations per Year

960 Citations

Semantic Scholar estimates that this publication has 960 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Epstein2012OralCO, title={Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.}, author={Joel Epstein and Juliette Thariat and Ren{\'e} Jean Bensadoun and Andrei Barasch and Barbara A. Murphy and Leanne Kolnick and Leslie L Popplewell and Ellie G Maghami}, journal={CA: a cancer journal for clinicians}, year={2012}, volume={62 6}, pages={400-22} }